NAMS
Price
$24.05
Change
+$0.10 (+0.42%)
Updated
Aug 29 closing price
Capitalization
2.71B
77 days until earnings call
QURE
Price
$16.33
Change
+$0.07 (+0.43%)
Updated
Aug 29 closing price
Capitalization
895.98M
58 days until earnings call
Interact to see
Advertisement

NAMS vs QURE

Header iconNAMS vs QURE Comparison
Open Charts NAMS vs QUREBanner chart's image
NewAmsterdam Pharma
Price$24.05
Change+$0.10 (+0.42%)
Volume$850.99K
Capitalization2.71B
uniQure
Price$16.33
Change+$0.07 (+0.43%)
Volume$711.24K
Capitalization895.98M
NAMS vs QURE Comparison Chart in %
Loading...
NAMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NAMS vs. QURE commentary
Sep 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAMS is a Hold and QURE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 02, 2025
Stock price -- (NAMS: $24.05 vs. QURE: $16.33)
Brand notoriety: NAMS and QURE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NAMS: 102% vs. QURE: 68%
Market capitalization -- NAMS: $2.71B vs. QURE: $895.98M
NAMS [@Biotechnology] is valued at $2.71B. QURE’s [@Biotechnology] market capitalization is $895.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NAMS’s FA Score shows that 1 FA rating(s) are green whileQURE’s FA Score has 0 green FA rating(s).

  • NAMS’s FA Score: 1 green, 4 red.
  • QURE’s FA Score: 0 green, 5 red.
According to our system of comparison, NAMS is a better buy in the long-term than QURE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NAMS’s TA Score shows that 4 TA indicator(s) are bullish while QURE’s TA Score has 6 bullish TA indicator(s).

  • NAMS’s TA Score: 4 bullish, 5 bearish.
  • QURE’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, QURE is a better buy in the short-term than NAMS.

Price Growth

NAMS (@Biotechnology) experienced а -3.80% price change this week, while QURE (@Biotechnology) price change was +4.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.70%. For the same industry, the average monthly price growth was +20.57%, and the average quarterly price growth was +29.45%.

Reported Earning Dates

NAMS is expected to report earnings on Nov 17, 2025.

QURE is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (-0.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NAMS($2.71B) has a higher market cap than QURE($896M). NAMS YTD gains are higher at: -6.420 vs. QURE (-7.531). QURE has higher annual earnings (EBITDA): -119.56M vs. NAMS (-237.93M). NAMS has more cash in the bank: 739M vs. QURE (377M). NAMS has less debt than QURE: NAMS (328K) vs QURE (66.7M). NAMS has higher revenues than QURE: NAMS (64M) vs QURE (14.3M).
NAMSQURENAMS / QURE
Capitalization2.71B896M302%
EBITDA-237.93M-119.56M199%
Gain YTD-6.420-7.53185%
P/E RatioN/AN/A-
Revenue64M14.3M448%
Total Cash739M377M196%
Total Debt328K66.7M0%
FUNDAMENTALS RATINGS
QURE: Fundamental Ratings
QURE
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
91
SEASONALITY SCORE
1..100
49

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NAMSQURE
RSI
ODDS (%)
Bearish Trend 4 days ago
58%
Bearish Trend 4 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
60%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
46%
Bullish Trend 4 days ago
79%
MACD
ODDS (%)
Bearish Trend 4 days ago
45%
Bullish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
55%
Bullish Trend 4 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
57%
Bullish Trend 4 days ago
74%
Advances
ODDS (%)
Bullish Trend 11 days ago
75%
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
70%
Bearish Trend 14 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
60%
Bearish Trend 4 days ago
85%
Aroon
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
NAMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ASCYX11.22-0.09
-0.80%
Alger Small Cap Growth Y
LMGFX72.46-0.62
-0.85%
ClearBridge International Growth FI
CSGEX14.49-0.13
-0.89%
BlackRock Advantage Small Cap Gr Inv A
BGGKX31.29-0.32
-1.01%
Baillie Gifford US Equity Growth K
WAAEX39.65-0.61
-1.52%
Wasatch Small Cap Growth Investor

NAMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAMS has been loosely correlated with QURE. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if NAMS jumps, then QURE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAMS
1D Price
Change %
NAMS100%
+0.42%
QURE - NAMS
56%
Loosely correlated
+0.43%
CRDF - NAMS
42%
Loosely correlated
+0.96%
IRON - NAMS
39%
Loosely correlated
-0.03%
BEAM - NAMS
38%
Loosely correlated
-2.91%
OCUL - NAMS
37%
Loosely correlated
-2.48%
More

QURE and

Correlation & Price change

A.I.dvisor indicates that over the last year, QURE has been loosely correlated with NAMS. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if QURE jumps, then NAMS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QURE
1D Price
Change %
QURE100%
+0.43%
NAMS - QURE
56%
Loosely correlated
+0.42%
BEAM - QURE
47%
Loosely correlated
-2.91%
ABSI - QURE
44%
Loosely correlated
-3.24%
ACLX - QURE
43%
Loosely correlated
-1.22%
NRIX - QURE
42%
Loosely correlated
-0.74%
More